PMC:7696151 / 15768-15964 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"461","span":{"begin":73,"end":81},"obj":"Species"},{"id":"462","span":{"begin":167,"end":175},"obj":"Species"},{"id":"467","span":{"begin":98,"end":101},"obj":"Chemical"}],"attributes":[{"id":"A461","pred":"tao:has_database_id","subj":"461","obj":"Tax:9606"},{"id":"A462","pred":"tao:has_database_id","subj":"462","obj":"Tax:9606"},{"id":"A467","pred":"tao:has_database_id","subj":"467","obj":"MESH:D006886"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"hed a randomized, double-blind, placebo-controlled trial performed on 83 patients to which 400 mg HCQ (n = 42) or placebo (n = 41) were administered for 48 weeks. All patients were naïve to HAART "}